MAIA Biotechnology, Inc.(NYSE Amex Equities : MAIA)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -6.45% | 171.14 | 0.0% | $784.22m | |
| AMGN | Amgen, Inc. | 0.43% | 248.36 | 1.5% | $592.28m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.66% | 298.83 | 1.9% | $438.24m | |
| GILD | Gilead Sciences, Inc. | 0.65% | 62.00 | 1.0% | $379.78m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.35% | 622.15 | 2.6% | $351.29m | |
| NVAX | Novavax, Inc. | -29.64% | 40.28 | 75.7% | $335.10m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -12.15% | 3.47 | 0.7% | $242.57m | |
| ILMN | Illumina, Inc. | -3.67% | 214.80 | 3.3% | $229.68m | |
| BIIB | Biogen, Inc. | 0.01% | 217.59 | 1.8% | $197.59m | |
| BNTX | BioNTech SE | -7.14% | 157.21 | 0.0% | $155.97m | |
| GOVX | GeoVax Labs, Inc. | -0.35% | 2.86 | 0.0% | $145.88m | |
| CRSP | CRISPR Therapeutics AG | -7.69% | 75.13 | 0.6% | $117.81m | |
| PLRX | Pliant Therapeutics, Inc. | 11.19% | 21.16 | 0.0% | $108.38m | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 7.19% | 22.65 | 0.0% | $105.42m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.00% | 95.70 | 4.2% | $98.26m |
Company Profile
MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. The company?s lead product THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on 3rd August, 2018 and is headquartered in Chicago.